REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/22/2026
Back to search
Official data from USPTO
SMRT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
06/23/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
01/31/2019
Registration date
06/22/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/22/2021
Last transaction
06/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
ADEMI, XHENETA
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Orthocell Limited
Representatives
Matthew J. Stark Price Heneveld LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Stem cells for medical purposes for regeneration of bone and soft tissue; medical preparations for use in connection with the regeneration of bone and soft tissue; guided tissue regeneration materialsmedical preparations for use in connection with the regeneration of bone and soft tissue; biological preparations for medical purposesfor the regeneration of bone and soft tissue; tissue-regenerative medical preparationsfor use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of tissues for medical usefor use in connection with the regeneration of bone and soft tissue; materials for dental treatmentdental preparations for use in connection with the regeneration of dental tissue; materials for making dental restorationsdental preparations for use in connection with the regeneration of dental tissue; dental repair materialsdental preparations for use in connection with the regeneration of dental tissue; dental restorative materialsdental preparations for use in connection with the regeneration of dental tissue; surgical implantsliving tissues grown from stem cells for use in connection with the regeneration of bone and soft tissue; collagen for medical use; medical preparations in the nature of biodegradable implants for use in guided tissue regenerationfor use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implant materials for use in guided tissue regeneration in surgeryfor use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implantable materials for use in guided tissue regenerationfor use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implants for guided tissue regenerationfor use in connection with the regeneration of bone and soft tissue; therapeutic agents for medical purposesfor the regeneration of bone and soft tissue; therapeutic biological tissue cultures for medical purposesfor the regeneration of bone and soft tissue; none of the aforementioned goods being or in relation to genomicssequencing of genomestranscriptomes or epigenomesmedical diagnostic assays and reagents for use in genetic sequencing and biochemical analysis
Class 42
Scientific and technological research services in the field of biomechanical and cellular therapeutic medical techniques and design servicesdesign of new tissue and bone regeneration products and techniques related to biomechanical and cellular therapeutic techniques
Class 44
Advisory services relating to medical services; physical therapy; medical services; medical advisory services; medical care services; medical health assessment services; medical treatment services for the regeneration of bone and soft tissue; provision of medical information; provision of medical services for the regeneration of bone and soft tissue; physical therapy services; all of the foregoing related to regeneration of bone and soft tissues and biomechanical and cellular therapeutic techniques
Publications
History of USPTO decisions and trademark events.
41 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/03/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/08/2021
FIMP
FINAL DISPOSITION PROCESSED
10/08/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/22/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/22/2021
GPNX
NOTIFICATION PROCESSED BY IB
04/12/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/06/2021
PUBO
PUBLISHED FOR OPPOSITION
04/06/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/17/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
03/04/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/04/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
03/04/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/04/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/25/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/05/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/26/2020
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
07/24/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/15/2020
ALIE
ASSIGNED TO LIE
06/29/2020
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02/18/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/07/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
01/31/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/04/2019
GNSL
LETTER OF SUSPENSION E-MAILED
12/04/2019
CNSL
SUSPENSION LETTER WRITTEN
12/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/01/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/01/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/01/2019
RFNT
REFUSAL PROCESSED BY IB
05/25/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/03/2019
RFRR
REFUSAL PROCESSED BY MPU
05/03/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/18/2019
CNRT
NON-FINAL ACTION WRITTEN
04/17/2019
DOCK
ASSIGNED TO EXAMINER
04/10/2019
MAFR
APPLICATION FILING RECEIPT MAILED
03/30/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/26/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/21/2019
Continuous trademark protection
Get notified about every new filing that threatens SMRT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.